Search
Quest Diagnostics Inc
DGXAdd to Watchlist
234.400USD
-1.740-0.74%
Close 08-14 16:00（ET）Quotes delayed by 15 min
25.78BMarket Cap
25.45P/E TTM
Forecast
Currency: USD Updated: 2026-08-14The current earnings forecast score of Quest Diagnostics Inc is 7.58, ranking 40 out of 74 in the Healthcare Providers & Services industry. The average price target is 198.00, with a high of 215.00 and a low of 169.18.
Analyst Rating
Based on
19
analysts
Buy
Current Rating
243.823
Target Price
+2.55%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
59
Total
9
Median
10
Average
Company name
Ratings
Analysts
Quest Diagnostics Inc
DGX
19
CVS Health Corp
CVS
29
HCA Healthcare Inc
HCA
26
Teladoc Health Inc
TDOC
25
Natera Inc
NTRA
24
Tenet Healthcare Corp
THC
23
1
2
3
...
12
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Quest Diagnostics Inc's expected revenue for the next quarter?
Quest Diagnostics Inc's expected revenue is 3.04B.
What is Quest Diagnostics Inc's price target?
Analysts forecast that Quest Diagnostics Inc's price target is USD 198.00, with the highest forecast at USD 215.00 and the lowest forecast at USD 169.18.
How have Quest Diagnostics IncDGX's recent earnings per share performed?
The market expectation was USD 2.87, while Quest Diagnostics IncDGX's earnings per share (EPS) for the previous quarter was USD 2.28. EPS for the next quarter is expected at USD 2.85.
What is the analyst rating for Quest Diagnostics Inc?
Based on the ratings of Quest Diagnostics Inc's stock from 19 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.